ImmPACT Bio USA is developing novel cell therapies for treating cancer.
ImmPACT Bio has raised $8.0M in total funding. The most recent round was Grant. The last funding was announced in February 2024.
ImmPACT Bio's investors include OrbiMed, Foresite Capital, Decheng Capital, venBio Partners, Johnson & Johnson Innovation.
ImmPACT Bio is headquartered in Camarillo, United States.
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
ImmPACT Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImmPACT Bio — Funding & Investors." VCBacked, February 28, 2024, https://www.vcbacked.co/company/immpact-bio. Accessed July 21, 2026.
VCBacked. (2024). ImmPACT Bio — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/immpact-bio
{{cite web |title=ImmPACT Bio — Funding & Investors |url=https://www.vcbacked.co/company/immpact-bio |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated